Johnson & Johnson Pays $5.5B Over Baby Powder Cancer Claims; Wall Street Rewards It Anyway

Johnson & Johnson has agreed to pay an estimated $5.5B (£4.1B) to resolve about 76,000 claims from women who say its talc powders left them with ovarian cancer. Despite the hefty payout, the stock reached $270 on Tuesday, an all-time high. That values the company at roughly $641B (£482B).

[https://www.ibtimes.co.uk/johnson-johnson-talc-settlement-legal-wins-1811193](https://www.ibtimes.co.uk/johnson-johnson-talc-settlement-legal-wins-1811193)